Abstract：
OBJECTIVE: Despite 10 years of prescribing scheduled medicines by Endorsed Midwives, little is known about prescribing practices.
BACKGROUND: Endorsed Midwives can prescribe scheduled medicines and have access to Medicare rebates to support service provision. Endorsed Midwives have the potential to improve access to medications for women, however, are met with barriers, including inconsistencies in state and national legislation.
OBJECTIVE: To search for what is published regarding Endorsed Midwife prescribing of scheduled medicines in Australia, report on the literature, synthesise the findings and discuss the results.
METHODS: A scoping review utilising the Joanna Brigg\'s Institute methodology. A search of CINAHL, PubMed, Science Direct and Medline databases was conducted. Seven peer-reviewed articles were identified; three discussion papers, one literature review and three research papers, published between 2016 and 2023 in English. Qualitative content analysis was used to identify topic areas.
RESULTS: Four topic areas were identified: 1) Endorsed Midwives increase women\'s access to prescribed medications; 2) the Pharmaceutical Benefits Scheme is restrictive and diminishes midwifery prescribing; 3) medication prescribing depends on internal and external structures; 4) professional relationships support prescribing.
CONCLUSIONS: The authority to prescribe augments Endorsed Midwives\' practice, improves timely access to medications and enhances role satisfaction. The effective use of midwifery prescribing is hampered by barriers such as the Pharmaceutical Benefits Scheme, inappropriate medication formularies, and poorly designed health service policy.
CONCLUSIONS: To fully utilise Endorsed Midwife prescribing in all settings of maternity care, further work is required to develop education, remove barriers, and demonstrate the safety and effectiveness of midwifery prescribing.
BACKGROUND: Endorsed Midwives can prescribe scheduled medicines and have access to Medicare rebates to support service provision. Endorsed Midwives have the potential to improve access to medications for women, however, are met with barriers, including inconsistencies in state and national legislation.
OBJECTIVE: To search for what is published regarding Endorsed Midwife prescribing of scheduled medicines in Australia, report on the literature, synthesise the findings and discuss the results.
METHODS: A scoping review utilising the Joanna Brigg\'s Institute methodology. A search of CINAHL, PubMed, Science Direct and Medline databases was conducted. Seven peer-reviewed articles were identified; three discussion papers, one literature review and three research papers, published between 2016 and 2023 in English. Qualitative content analysis was used to identify topic areas.
RESULTS: Four topic areas were identified: 1) Endorsed Midwives increase women\'s access to prescribed medications; 2) the Pharmaceutical Benefits Scheme is restrictive and diminishes midwifery prescribing; 3) medication prescribing depends on internal and external structures; 4) professional relationships support prescribing.
CONCLUSIONS: The authority to prescribe augments Endorsed Midwives\' practice, improves timely access to medications and enhances role satisfaction. The effective use of midwifery prescribing is hampered by barriers such as the Pharmaceutical Benefits Scheme, inappropriate medication formularies, and poorly designed health service policy.
CONCLUSIONS: To fully utilise Endorsed Midwife prescribing in all settings of maternity care, further work is required to develop education, remove barriers, and demonstrate the safety and effectiveness of midwifery prescribing.
摘要：
目标：尽管认可的助产士开出了10年的预定药物，对处方实践知之甚少。
背景：认可的助产士可以开预定的药物，并可以获得Medicare回扣以支持服务提供。认可的助产士有可能改善妇女获得药物的机会，然而,遇到障碍，包括州和国家立法的不一致。
目的：为了搜索澳大利亚关于认可助产士处方预定药物的发布内容，关于文献的报告，综合研究结果并讨论结果。
方法：使用JoannaBrigg研究所方法的范围审查。搜索CINAHL,PubMed,进行了ScienceDirect和Medline数据库。确定了七篇同行评审的文章；三篇讨论论文，一篇文献综述和三篇研究论文，在2016年至2023年之间以英文出版。定性内容分析用于确定主题领域。
结果：确定了四个主题领域：1）认可的助产士增加了妇女获得处方药的机会；2）药物福利计划具有限制性并减少了助产处方；3）药物处方取决于内部和外部结构；4）专业关系支持处方。
结论：处方授权助产士的实践，改善及时获得药物并提高角色满意度。药物福利计划等障碍阻碍了助产处方的有效使用，不适当的药物配方，和设计不当的卫生服务政策。
结论：为了在所有产妇护理环境中充分利用认可的助产士处方，发展教育需要进一步的工作，消除障碍，并证明助产处方的安全性和有效性。
背景：认可的助产士可以开预定的药物，并可以获得Medicare回扣以支持服务提供。认可的助产士有可能改善妇女获得药物的机会，然而,遇到障碍，包括州和国家立法的不一致。
目的：为了搜索澳大利亚关于认可助产士处方预定药物的发布内容，关于文献的报告，综合研究结果并讨论结果。
方法：使用JoannaBrigg研究所方法的范围审查。搜索CINAHL,PubMed,进行了ScienceDirect和Medline数据库。确定了七篇同行评审的文章；三篇讨论论文，一篇文献综述和三篇研究论文，在2016年至2023年之间以英文出版。定性内容分析用于确定主题领域。
结果：确定了四个主题领域：1）认可的助产士增加了妇女获得处方药的机会；2）药物福利计划具有限制性并减少了助产处方；3）药物处方取决于内部和外部结构；4）专业关系支持处方。
结论：处方授权助产士的实践，改善及时获得药物并提高角色满意度。药物福利计划等障碍阻碍了助产处方的有效使用，不适当的药物配方，和设计不当的卫生服务政策。
结论：为了在所有产妇护理环境中充分利用认可的助产士处方，发展教育需要进一步的工作，消除障碍，并证明助产处方的安全性和有效性。
